FDA Inspection
Taro Pharmaceuticals U.S.A., Inc.Taro Pharmaceuticals U.S.A., Inc. – FDA Inspection, Mar 8, 2012
Record Details
This FDA Inspection record concerns Taro Pharmaceuticals U.S.A., Inc., with an inspection on March 8, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 8, 2012
- Product Type
- Drugs
View Company Profile
ID · f0b7fd89-5e15-4c11-bfd0-d4a015a2b591
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 769594
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 314.80(f)(1)Wrong form - domestic ADE
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Taro Pharmaceuticals U.S.A., Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 19, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 18, 2013 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| May 29, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Taro Pharmaceuticals U.S.A., Inc.
- FDA Inspection 1066575 - 2018-08-27
- FDA Inspection 907479 - 2014-12-19
- FDA Inspection 827465 - 2013-04-18
- FDA Inspection 592198 - 2009-05-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.